688363 華熙生物
按盤價 
50.560 +0.510 (+1.019%) | 2024/09 - 九個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 5.186 | 8.728 | 15.745 | 14.597 | 13.497 |
| 總資產報酬率 ROA (%) | 4.220 | 6.910 | 11.997 | 11.835 | 12.085 |
| 投入資產回報率 ROIC (%) | 4.952 | 8.259 | 14.678 | 13.979 | 13.390 | 邊際利潤分析 |
| 銷售毛利率 (%) | 73.929 | 73.320 | 76.990 | 78.066 | 81.408 |
| 營業利潤率 (%) | 11.256 | 11.659 | 17.869 | 18.302 | 28.755 |
| 息稅前利潤/營業總收入 (%) | 11.083 | 11.042 | 17.101 | 17.982 | 28.806 |
| 淨利潤/營業總收入 (%) | 9.266 | 9.591 | 15.118 | 15.675 | 24.500 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 104.354 | 90.875 | 91.276 | 87.827 | 93.194 |
| 價值變動淨收益/利潤總額(%) | -1.137 | 0.398 | 1.036 | 3.150 | 4.944 |
| 營業外收支淨額/利潤總額(%) | 0.102 | -0.950 | -0.018 | -1.725 | 0.244 | 償債能力分析 |
| 流動比率 (X) | 2.361 | 2.558 | 2.447 | 2.845 | 6.626 |
| 速動比率 (X) | 1.203 | 1.629 | 1.741 | 2.338 | 5.764 |
| 資產負債率 (%) | 18.816 | 17.551 | 23.023 | 24.005 | 12.223 |
| 帶息債務/全部投入資本 (%) | -0.307 | 0.173 | 3.478 | 2.381 | -1.451 |
| 股東權益/帶息債務 (%) | -30,870.666 | 55,551.426 | 2,675.714 | 3,924.090 | -6,794.689 |
| 股東權益/負債合計 (%) | 429.348 | 467.119 | 331.894 | 316.387 | 718.383 |
| 利息保障倍數 (X) | -60.180 | -21.787 | -22.350 | -1,798.523 | -1,482.564 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 34.123 | 26.538 | 23.920 | 27.976 | 50.866 |
| 存貨周轉天數 (天) | 327.385 | 254.954 | 230.122 | 196.693 | 290.987 |
| 備註： | 即時報價更新時間為 14/02/2025 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
